Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1995 1
1997 5
1998 2
1999 2
2000 4
2001 7
2002 2
2003 3
2004 4
2005 6
2006 10
2007 12
2008 10
2009 9
2010 14
2011 9
2012 12
2013 12
2014 18
2015 13
2016 15
2017 13
2018 10
2019 8
2020 9
2021 9
2022 14
2023 4
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Results by year

Filters applied: . Clear all
Page 1
« Médecine de ville et essai clinique dans le parcours de soins : aspects organisationnels, réglementaires, outils ».
Laviolle B, Diebolt V, Duchossoy L, Anglaret X, Béhier JM, Bertoye PH, Chapron A, Comet D, Cornu C, Fouret C, Galaup A, Guérin A, Hoen B, Imbert P, Lang M, Le Louarn A, Mezerette B, Sénéchal S, Simon T, Traineau P. Laviolle B, et al. Among authors: anglaret x. Therapie. 2022 Jan-Feb;77(1):25-36. doi: 10.1016/j.therap.2022.01.001. Epub 2022 Jan 5. Therapie. 2022. PMID: 35090751 Free article. French. No abstract available.
HIV, Pregnancy, and Isoniazid Preventive Therapy.
Tiendrebeogo T, Anglaret X, Becquet R. Tiendrebeogo T, et al. Among authors: anglaret x. N Engl J Med. 2020 Mar 19;382(12):1184. doi: 10.1056/NEJMc1916664. N Engl J Med. 2020. PMID: 32187482 No abstract available.
Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.
Madelain V, Mentré F, Baize S, Anglaret X, Laouénan C, Oestereich L, Nguyen THT, Malvy D, Piorkowski G, Graw F, Günther S, Raoul H, de Lamballerie X, Guedj J. Madelain V, et al. Among authors: anglaret x. CPT Pharmacometrics Syst Pharmacol. 2020 May;9(5):258-271. doi: 10.1002/psp4.12510. Epub 2020 Apr 28. CPT Pharmacometrics Syst Pharmacol. 2020. PMID: 32198838 Free PMC article. Review.
Elite and viremic HIV-1 controllers in West Africa.
N'takpé JB, Gabillard D, Moh R, Gardiennet E, Toni TD, Kouame GM, Badje A, Emieme A, Karcher S, Le Carrou J, Ménan H, Danel C, Eholie SP, Rouzioux C, Anglaret X, Lambotte O. N'takpé JB, et al. Among authors: anglaret x. AIDS. 2022 Jan 1;36(1):29-38. doi: 10.1097/QAD.0000000000003072. AIDS. 2022. PMID: 34524145 Free PMC article. Clinical Trial.
Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial.
Eholie SP, Ekouevi DK, Chazallon C, Charpentier C, Messou E, Diallo Z, Zoungrana J, Minga A, Ngom Gueye NF, Hawerlander D, Dembele F, Colin G, Tchounga B, Karcher S, Le Carrou J, Tchabert-Guié A, Toni TD, Ouédraogo AS, Bado G, Toure Kane C, Seydi M, Poda A, Mensah E, Diallo I, Drabo YJ, Anglaret X, Brun-Vezinet F; FIT-2 study group. Eholie SP, et al. Among authors: anglaret x. Lancet HIV. 2024 Jun;11(6):e380-e388. doi: 10.1016/S2352-3018(24)00085-7. Epub 2024 May 10. Lancet HIV. 2024. PMID: 38740027 Free article. Clinical Trial.
232 results